Congresswoman Johnson Votes to Bring Down Prescription Drug Prices with House Passage of H.R.3, the Elijah E. Cummings Lower Drug Costs Now Act
Washington, DC – Today, Rep. Johnson voted to pass H.R.3, the Elijah E. Cummings Lower Drug Costs Now Act, which
will help bring down the cost of prescription drugs and level the playing field for American patients who are paying
more for their medicines than patients in other countries. This bill also gives Medicare the power to negotiate directly
with drug companies. The lower prices that are negotiated by Medicare will be transparent, so that private insurance
companies can make the same prices available to their consumers. It also creates a new $2000 out-of-pocket limit on
prescription drug costs for Medicare beneficiaries.
“Constituents in the 30th District are facing skyrocketing prescription drug prices, forcing many to choose between their
medications and putting food on the table or meeting other basic needs,” said Congresswoman Johnson.
“That’s unacceptable, and it’s why I pledged to make this issue one of my top priorities this year. I was proud to
vote for H.R.3 today to deliver on that promise. I’m pleased that the bill invests the money it saves into expanding
Medicare’s benefits to include dental, vision, and hearing; assisting innovation in the search for new cures and
treatments; and helping combat the opioid crisis. I urge the Senate to take up and pass H.R.3, and send it to the
President’s desk for his signature.”